Loading viewer...
annual_report
Format: PDF annual_report
Alzamend Neuro, Inc. (NASDAQ: ALZN) is a biotech company filing its annual report for fiscal year ended April 30, 2023. The company operates from Atlanta, Georgia and is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
ADM 2009 Form 10-K Annual Report
annual_reportannual_report
96 Pages
Archer Daniels Midland Company
annual_report
Citigroup
annual_report
105 Pages
Action for Development
annual_report
Barclays
annual_report
Colonial Properties Trust
Bahrain Petroleum Company Annual Report 2024
annual_reportannual_report
69 Pages
Bahrain Petroleum Company (Bapco)